Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wicks

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
The Journal of Experimental Medicine|July 18, 2001
Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantationM Ernst, M Inglese, P Waring, et al.
Arthritis Research & Therapy|June 18, 2015
Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritisAnnemarie E M van Nieuwenhuijze, Fons A van de Loo, Birgitte Walgreen, et al.
The Journal of Clinical Investigation|May 20, 2006
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisPeter K K Wong, Paul J Egan, Ben A Croker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2014
Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritisXiao Liu, Ben A Croker, Ian K Campbell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2019
The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β ReleaseMaryam Rashidi, Daniel S Simpson, Anne Hempel, et al.
The American Journal of Pathology|January 1, 2016
G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune UveoretinitisGabrielle L Goldberg, Ann L Cornish, Jane Murphy, et al.
Clinical & Translational Immunology|November 18, 2020
Inhibition of interleukin-1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritisDragana Dragoljevic, Man Kit Sam Lee, Cynthia Louis, et al.
Iscience|December 22, 2021
Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cellsMan Lyang Kim, Melinda Y Hardy, Laura E Edgington-Mitchell, et al.
Arthritis and Rheumatism|October 4, 2005
Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic miceCaroline Tan Sardjono, Patricia L Mottram, Nicholas C van de Velde, et al.
Annals of the Rheumatic Diseases|December 16, 2018
NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathologySusan Schlenner, Emanuela Pasciuto, Vasiliki Lagou, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Experimental Medicine|July 18, 2001
Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantationM Ernst, M Inglese, P Waring, et al.
Arthritis Research & Therapy|June 18, 2015
Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritisAnnemarie E M van Nieuwenhuijze, Fons A van de Loo, Birgitte Walgreen, et al.
The Journal of Clinical Investigation|May 20, 2006
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisPeter K K Wong, Paul J Egan, Ben A Croker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2014
Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritisXiao Liu, Ben A Croker, Ian K Campbell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2019
The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β ReleaseMaryam Rashidi, Daniel S Simpson, Anne Hempel, et al.
The American Journal of Pathology|January 1, 2016
G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune UveoretinitisGabrielle L Goldberg, Ann L Cornish, Jane Murphy, et al.
Clinical & Translational Immunology|November 18, 2020
Inhibition of interleukin-1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritisDragana Dragoljevic, Man Kit Sam Lee, Cynthia Louis, et al.
Iscience|December 22, 2021
Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cellsMan Lyang Kim, Melinda Y Hardy, Laura E Edgington-Mitchell, et al.
Arthritis and Rheumatism|October 4, 2005
Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic miceCaroline Tan Sardjono, Patricia L Mottram, Nicholas C van de Velde, et al.
Annals of the Rheumatic Diseases|December 16, 2018
NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathologySusan Schlenner, Emanuela Pasciuto, Vasiliki Lagou, et al.
Pageof 18